Info

Serologicals Corporation is a global provider of biological products and enabling technologies, which are essential for the research, development and manufacturing of biologically based life science products. Our products and technologies are used in a wide variety of innovative applications within the areas of oncology, hematology, immunology, cardiology and infectious diseases, as well as in the study of molecular biology. Our customers include many of the leading life science companies throughout the world. They use our products to advance their products from research and development to manufacturing and, ultimately, to improve the health of people worldwide. Serologicals conducts a focused R & D program to discover new and innovative products and technologies and deliver them to scientists around the world for further use and development. Serologicals Corporation, headquartered in Atlanta, Georgia, has more than 750 employees worldwide, and its shares are traded on the NASDAQ national stock market under the symbol SERO. In 2001, Serologicals Corporation earned recognition as one of the top ten best-performing public companies in Georgia, was one of Bloomberg's top 100 performing stocks and was named to the prestigious "Fast Tech 50" list of Georgia companies for the fifth consecutive year.